Just had a chance to listen to Will's presentation and I heard somethings I have not heard before. Everything so far has been in the US or Europe. Nothing has ever been said about Asia, South America, India or China. now we hear about Brazil and Japan. My question is what is the market world wide and what is required in these other markets? He also said the company plans on going alone with no partner, interesting to say the least.
Japan is tough because they want the stuff made in Japan. But they have softened that in recent years.
Brazil is impossible because of government agency conflicts. They follow good standards by at a "glacial pace." Brazil has to rely on imports for critical medicines. Particularly the red label, prescription ones.